Cosmetic cross-reference

919-30-2

CAS 919-30-2

919-30-2 (CAS 919-30-2) is a pharmaceutical compound with 1 bioactivity target and 0 adverse event associations.

SOURCE NLM DailyMed
Label records
0
SOURCE EMBL-EBI ChEMBL
Bioactivity
1
SOURCE DrugCentral
Adverse signals
0
SOURCE IUPHAR/BPS
PubMed IDs
0
SOURCE EMBL-EBI ChEMBL B25820EEF0F0

Compound Identity

Matched identifiers and naming fields for the pharmaceutical compound record.

Primary Name
919-30-2
CAS Number
919-30-2
UNII
L8S6UBW552
InChIKey
WYTZZXDRDKSJID-UHFFFAOYSA-N
ChEMBL ID
CHEMBL1542365
Molecule Type
Small molecule
Source Match
EMBL-EBI ChEMBL (INCHIKEY)
Synonyms and normalized names
3-(TRIETHOXYSILYL)PROPYLAMINE
SOURCE Ingredients table / CosIng profile same-CAS cross-reference

Cross-Reference to Cosmetics

Same-CAS ingredient record found in the cosmetics vertical.

SOURCE EMBL-EBI ChEMBL 1 bioactivity row

Bioactivity & Target Interactions

Target-level activity records with assay counts, activity type, and measured value where present.

TargetActivity ValueAssaysOrganism
- Potency 29526.25 nM 2 -
SOURCE NLM RxNorm 1 name row

Drug Names / RxNorm

Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.

NameRxCUI TypeSource
3-(TRIETHOXYSILYL)PROPYLAMINE 1425088 SU MTHSPL
SOURCE Rendered pharma page rows FAQPage JSON-LD

Frequently Asked Questions

Short answers generated only from the same visible source-linked rows on this page.

What is 919-30-2 used for in pharmaceutical contexts?

919-30-2 (CAS 919-30-2) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.

What are the known adverse events for 919-30-2?

No adverse-event association or SIDER side-effect rows are rendered for 919-30-2 in this page query. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.

Is 919-30-2 also used in cosmetics?

Yes. The ingredients table has a same-CAS cosmetic profile for Aminopropyl Triethoxysilane with EU status "permitted".

What clinical phase is 919-30-2 in?

No phase 1-4 clinical development badge is rendered for 919-30-2 because the matched compound identifier rows do not contain a max-phase value.